Single Residue Determines the Specificity of Neutrophil Elastase for Shigella Virulence Factors

Journal of Molecular Biology

Volumn 377, Issue 4, 2008, Pages 1053-1066

  Averhoff, Petra ^a   Kolbe, Michael ^a   Zychlinsky, Arturo ^a   Weinrauch, Yvette ^b  

^a MAX PLANCK INSTITUTE FOR INFECTION BIOLOGY   (Germany)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

cathepsin G; neutrophil elastase; Shigella flexneri; specificity; virulence factors

Indexed keywords

ALANINE; AMINO ACID; ISOLEUCINE; LEUKOCYTE ELASTASE; THREONINE; UNCLASSIFIED DRUG; VIRULENCE FACTOR; VIRULENCE FACTOR IPAB;

ARTICLE; CONTROLLED STUDY; ENTEROBACTERIACEAE; ENZYME KINETICS; ENZYME STRUCTURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN STRUCTURE; SENSITIVITY AND SPECIFICITY; SHIGELLA;

ENTEROBACTERIACEAE; NEGIBACTERIA; SHIGELLA; SHIGELLA FLEXNERI;

EID: 40849092320     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2007.12.034     Document Type: Article

References (62)

1. Borregaard N., and Cowland J.B. Granules of the human neutrophilic polymorphonuclear leukocyte. Blood 89 (1997) 3503-3521
2. Wiedow O., Muhle K., Streit V., and Kameyoshi Y. Human eosinophils lack human leukocyte elastase. Biochim. Biophys. Acta 1315 (1996) 185-187
3. Watorek W., van Halbeek H., and Travis J. The isoforms of human neutrophil elastase and cathepsin G differ in their carbohydrate side chain structures. Biol. Chem. Hoppe-Seyler 374 (1993) 385-393
4. Lesk A.M., and Fordham W.D. Conservation and variability in the structures of serine proteinases of the chymotrypsin family. J. Mol. Biol. 258 (1996) 501-537
5. Sinha S., Watorek W., Karr S., Giles J., Bode W., and Travis J. Primary structure of human neutrophil elastase. Proc. Natl Acad. Sci. USA 84 (1987) 2228-2232
6. 2: a Janus-faced proteinase with two opposite specificities. EMBO J. 15 (1996) 5481-5491
7. Pham C.T. Neutrophil serine proteases: specific regulators of inflammation. Nat. Rev. Immunol. 6 (2006) 541-550
8. Tkalcevic J., Novelli M., Phylactides M., Iredale J.P., Segal A.W., and Roes J. Impaired immunity and enhanced resistance to endotoxin in the absence of neutrophil elastase and cathepsin G. Immunity 12 (2000) 201-210
9. Belaaouaj A., McCarthy R., Baumann M., Gao Z., Ley T.J., Abraham S.N., and Shapiro S.D. Mice lacking neutrophil elastase reveal impaired host defense against Gram negative bacterial sepsis. Nat. Med. 4 (1998) 615-618
10. + flux. Nature 416 (2002) 291-297
11. Weinrauch Y., Drujan D., Shapiro S.D., Weiss J., and Zychlinsky A. Neutrophil elastase targets virulence factors of enterobacteria. Nature 417 (2002) 91-94
12. Mayer-Scholl A., Averhoff P., and Zychlinsky A. How do neutrophils and pathogens interact?. Curr. Opin. Microbiol. 7 (2004) 62-66
13. Finlay B.B., and Falkow S. Comparison of the invasion strategies used by Salmonella choleraesuis, Shigella flexneri and Yersinia enterocolitica to enter cultured animal cells: endosome acidification is not required for bacterial invasion or intracellular replication. Biochimie 70 (1988) 1089-1099
14. Nhieu G.T., Enninga J., Sansonetti P., and Grompone G. Tyrosine kinase signaling and type III effectors orchestrating Shigella invasion. Curr. Opin. Microbiol. 8 (2005) 16-20
15. Cossart P., and Sansonetti P.J. Bacterial invasion: the paradigms of enteroinvasive pathogens. Science 304 (2004) 242-248
16. Ogawa M., and Sasakawa C. Intracellular survival of Shigella. Cell. Microbiol. 8 (2006) 177-184
17. Suzuki T., Miki H., Takenawa T., and Sasakawa C. Neural Wiskott-Aldrich syndrome protein is implicated in the actin-based motility of Shigella flexneri. EMBO J. 17 (1998) 2767-2776
18. Egile C., Loisel T.P., Laurent V., Li R., Pantaloni D., Sansonetti P.J., and Carlier M.F. Activation of the CDC42 effector N-WASP by the Shigella flexneri IcsA protein promotes actin nucleation by Arp2/3 complex and bacterial actin-based motility. J. Cell Biol. 146 (1999) 1319-1332
19. Mandic-Mulec I., Weiss J., and Zychlinsky A. Shigella flexneri is trapped in polymorphonuclear leukocyte vacuoles and efficiently killed. Infect. Immun. 65 (1997) 110-115
20. Hartley B.S., and Shotton D.M. Pancreatic elastase. In: Boyer P.D. (Ed). The Enzymes vol. III (1971), Academic Press, New York 323-373
21. Salvesen G., Farley D., Shuman J., Przybyla A., Reilly C., and Travis J. Molecular cloning of human cathepsin G: structural similarity to mast cell and cytotoxic T lymphocyte proteinases. Biochemistry 26 (1987) 2289-2293
22. Le Huerou I., Wicker C., Guilloteau P., Toullec R., and Puigserver A. Isolation and nucleotide sequence of cDNA clone for bovine pancreatic anionic trypsinogen. Structural identity within the trypsin family. Eur. J. Biochem. 193 (1990) 767-773
23. Pjura P.E., Lenhoff A.M., Leonard S.A., and Gittis A.G. Protein crystallization by design: chymotrypsinogen without precipitants. J. Mol. Biol. 300 (2000) 235-239
24. Edgar R.C. MUSCLE: multiple sequence alignment with high accuracy and high throughput. Nucleic Acids Res. 32 (2004) 1792-1797
25. Goodstadt L., and Ponting C.P. CHROMA: consensus-based colouring of multiple alignments for publication. Bioinformatics 17 (2001) 845-846
26. Navia M.A., McKeever B.M., Springer J.P., Lin T.Y., Williams H.R., Fluder E.M., et al. Structure of human neutrophil elastase in complex with a peptide chloromethyl ketone inhibitor at 1.84-A resolution. Proc. Natl Acad. Sci. USA 86 (1989) 7-11
27. De Lano W.L. The PyMOL Molecular Graphics System (2002), DeLano Scientific, San Carlos, CA, USA
28. Perona J.J., and Craik C.S. Structural basis of substrate specificity in the serine proteases. Protein Sci. 4 (1995) 337-360
29. Hedstrom L., Perona J.J., and Rutter W.J. Converting trypsin to chymotrypsin: residue 172 is a substrate specificity determinant. Biochemistry 33 (1994) 8757-8763
30. Hedstrom L., Szilagyi L., and Rutter W.J. Converting trypsin to chymotrypsin: the role of surface loops. Science 255 (1992) 1249-1253
31. Kleywegt G.J. Use of non-crystallographic symmetry in protein structure refinement. Acta Crystallogr. Sect. D 52 (1996) 842-857
32. Bode W., Meyer Jr. E., and Powers J.C. Human leukocyte and porcine pancreatic elastase: X-ray crystal structures, mechanism, substrate specificity, and mechanism-based inhibitors. Biochemistry 28 (1989) 1951-1963
33. Bode W., Wei A.Z., Huber R., Meyer E., Travis J., and Neumann S. X-ray crystal structure of the complex of human leukocyte elastase (PMN elastase) and the third domain of the turkey ovomucoid inhibitor. EMBO J. 5 (1986) 2453-2458
34. Krem M.M., and Di Cera E. Molecular markers of serine protease evolution. EMBO J. 20 (2001) 3036-3045
35. Wei A.Z., Mayr I., and Bode W. The refined 2.3 A crystal structure of human leukocyte elastase in a complex with a valine chloromethyl ketone inhibitor. FEBS Lett. 234 (1988) 367-373
36. Gullberg U., Lindmark A., Lindgren G., Persson A.M., Nilsson E., and Olsson I. Carboxyl-terminal prodomain-deleted human leukocyte elastase and cathepsin G are efficiently targeted to granules and enzymatically activated in the rat basophilic/mast cell line RBL. J. Biol. Chem. 270 (1995) 12912-12918
37. Schechter I., and Berger A. On the active site of proteases: 3. Mapping the active site of papain; specific peptide inhibitors of papain. Biochem. Biophys. Res. Commun. 32 (1968) 898-902
38. Harper J.W., Cook R.R., Roberts C.J., McLaughlin B.J., and Powers J.C. Active site mapping of the serine proteases human leukocyte elastase, cathepsin G, porcine pancreatic elastase, rat mast cell proteases I and II. Bovine chymotrypsin A alpha, and Staphylococcus aureus protease V-8 using tripeptide thiobenzyl ester substrates. Biochemistry 23 (1984) 2995-3002
39. Zimmerman M., and Ashe B.M. Substrate specificity of the elastase and the chymotrypsin-like enzyme of the human granulocyte. Biochim. Biophys. Acta 480 (1977) 241-245
40. Nakajima K., Powers J.C., Ashe B.M., and Zimmerman M. Mapping the extended substrate binding site of cathepsin G and human leukocyte elastase. Studies with peptide substrates related to the alpha 1-protease inhibitor reactive site. J. Biol. Chem. 254 (1979) 4027-4032
41. Tanaka T., Minematsu Y., Reilly C.F., Travis J., and Powers J.C. Human leukocyte cathepsin G. Subsite mapping with 4-nitroanilides, chemical modification, and effect of possible cofactors. Biochemistry 24 (1985) 2040-2047
42. Dall'Acqua W., Halin C., Rodrigues M.L., and Carter P. Elastase substrate specificity tailored through substrate-assisted catalysis and phage display. Protein Eng. 12 (1999) 981-987
43. Perona J.J., and Craik C.S. Evolutionary divergence of substrate specificity within the chymotrypsin-like serine protease fold. J. Biol. Chem. 272 (1997) 29987-29990
44. Horwitz M., Benson K.F., Duan Z., Li F.Q., and Person R.E. Hereditary neutropenia: dogs explain human neutrophil elastase mutations. Trends Mol. Med. 10 (2004) 163-170
45. Hedstrom L., Farr-Jones S., Kettner C.A., and Rutter W.J. Converting trypsin to chymotrypsin: ground-state binding does not determine substrate specificity. Biochemistry 33 (1994) 8764-8769
46. Steitz T.A., and Shulman R.G. Crystallographic and NMR studies of the serine proteases. Annu. Rev. Biophys. Bioeng. 11 (1982) 419-444
47. Perona J.J., Hedstrom L., Rutter W.J., and Fletterick R.J. Structural origins of substrate discrimination in trypsin and chymotrypsin. Biochemistry 34 (1995) 1489-1499
48. Graf L., Craik C.S., Patthy A., Roczniak S., Fletterick R.J., and Rutter W.J. Selective alteration of substrate specificity by replacement of aspartic acid-189 with lysine in the binding pocket of trypsin. Biochemistry 26 (1987) 2616-2623
49. Hajjar E., Korkmaz B., Gauthier F., Brandsdal B.O., Witko-Sarsat V., and Reuter N. Inspection of the binding sites of proteinase 3 for the design of a highly specific substrate. J. Med. Chem. 49 (2006) 1248-12460
50. Krem M.M., Rose T., and Di Cera E. The C-terminal sequence encodes function in serine proteases. J. Biol. Chem. 274 (1999) 28063-28066
51. Birrer P., McElvaney N.G., Rudeberg A., Sommer C.W., Liechti-Gallati S., Kraemer R., et al. Protease-antiprotease imbalance in the lungs of children with cystic fibrosis. Am. J. Respir. Crit. Care Med. 150 (1994) 207-213
52. Bruce M.C., Poncz L., Klinger J.D., Stern R.C., Tomashefski Jr. J.F., and Dearborn D.G. Biochemical and pathologic evidence for proteolytic destruction of lung connective tissue in cystic fibrosis. Am. Rev. Respir. Dis. 132 (1985) 529-535
53. Schuster A., Fahy J.V., Ueki I., and Nadel J.A. Cystic fibrosis sputum induces a secretory response from airway gland serous cells that can be prevented by neutrophil protease inhibitors. Eur. Respir. J. 8 (1995) 10-14
54. Turner D.L., and Weintraub H. Expression of achaete-scute homolog 3 in Xenopus embryos converts ectodermal cells to a neural fate. Genes Dev. 8 (1994) 1434-1447
55. Rupp R.A., Snider L., and Weintraub H. Xenopus embryos regulate the nuclear localization of XMyoD. Genes Dev. 8 (1994) 1311-1323
56. Li F.Q., and Horwitz M. Characterization of mutant neutrophil elastase in severe congenital neutropenia. J. Biol. Chem. 276 (2001) 14230-14241
57. Guichon A., Hersh D., Smith M.R., and Zychlinsky A. Structure-function analysis of the Shigella virulence factor IpaB. J. Bacteriol. 183 (2001) 1269-1276
58. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 (1970) 680-685
59. Barzu S., Nato F., Rouyre S., Mazie J.C., Sansonetti P., and Phalipon A. Characterization of B-cell epitopes on IpaB, an invasion-associated antigen of Shigella flexneri: identification of an immunodominant domain recognized during natural infection. Infect. Immun. 61 (1993) 3825-3831
60. Goldberg M.B., Barzu O., Parsot C., and Sansonetti P.J. Unipolar localization and ATPase activity of IcsA, a Shigella flexneri protein involved in intracellular movement. Infect. Agents Dis. 2 (1993) 210-211
61. Prasadarao N.V., Wass C.A., Weiser J.N., Stins M.F., Huang S.H., and Kim K.S. Outer membrane protein A of Escherichia coli contributes to invasion of brain microvascular endothelial cells. Infect. Immun. 64 (1996) 146-153
62. Hume P.J., McGhie E.J., Hayward R.D., and Koronakis V. The purified Shigella IpaB and Salmonella SipB translocators share biochemical properties and membrane topology. Mol. Microbiol. 49 (2003) 425-439